• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALUNG TECHNOLOGIES, INC. HEMOLUNG RAS; CANNULA, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALUNG TECHNOLOGIES, INC. HEMOLUNG RAS; CANNULA, CATHETER Back to Search Results
Model Number HL-CR4-01-000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hematuria (2558)
Event Date 02/23/2020
Event Type  Injury  
Event Description
Alung technologies, inc.Recieved a report of a patient experiencing pink urine post hemolung cateter placement.The catheter line was checked for kinkin and blood flow setting was decreased.Persistence of gross hematuria along with high pfh and other parameters led to decision to decatheterate.
 
Manufacturer Narrative
Patient information was not provided.Lot/serial number was not provided, so the udi and expiration date could not be determined.As lot number was not provided, manufacturing date could not be determined alung technologies, inc.Manufactures the hemolung ras and catheter.The incident occurred in minneapolis, minnesota.Medical intervention was required to prevent further patient injury.Alung technologies, inc.Recieved a report of a patient experiencing pink urine post hemolung cateter placement.The catheter line was checked for kinkin and blood flow setting was decreased.Persistence of gross hematuria along with high pfh and other parameters led to decision to decatheterate.The data log from hemolung therapy has been retrieved and reviewed by both clinical and software engineering staff.Review of blood flow and co2 removal graphs show that hemolung therapy was provided as intended without any unexpected alarms or malfunctions.The returned device was evaluated for any abnormalities.There were no findings within the analysis.There were no mechanical indications that the device would have malfunctioned.No capa was opened because of this event.Increased plasma free hemoglobin is a known possible occurrence with hemolung therapy.Examination of the returned disposables as well as the controller data log show that hemolung therapy was provided as intended.Alung technologies, inc.Will continue to monitor any issues as they are reported.This mdr is being filed in response to a retrospective view of all alung technologies, inc.Complaints, which identified that the reporting decision for this complaint was not correct.This mdr is being filed retrospectively to correct the error in the reporting decision.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEMOLUNG RAS
Type of Device
CANNULA, CATHETER
Manufacturer (Section D)
ALUNG TECHNOLOGIES, INC.
2500 jane st
suite 1
pittsburgh PA 15203
Manufacturer Contact
ryan coyle
2500 jane st
suite 1
pittsburgh, PA 15203
MDR Report Key16200005
MDR Text Key307659341
Report Number3009763347-2023-00043
Device Sequence Number1
Product Code DQR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
DEN210006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/18/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberHL-CR4-01-000
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/29/2020
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-